ObjectivesTo assess performance of interstitial pneumonia (IP) with autoimmune features (IPAF) criteria in clinical practice and describe the utility of additional workup in identifying patients with
ERT, enzyme replacement therapy; GFR, glomerular filtration rate; LVMI, left ventricular mass index; LVH, left ventricular hypertrophy (defined as LVMI≥110 g/m2). Data are mean ± SD, unless otherwise
